Jumia Technologies AG - ADR vs Smith & Nephew plc — how do they compare? Jumia Technologies AG - ADR trades at $6.35 (market cap $783.99M), while Smith & Nephew plc trades at $30.45 (market cap $12.64B). The key difference: Smith & Nephew plc is far larger — about 16.1× Jumia Technologies AG - ADR's market cap, and Smith & Nephew plc pays a 2.57% dividend while Jumia Technologies AG - ADR pays none. Which is the better fit depends on your goals.
| JMIA | SNN | |
|---|---|---|
Market Cap | $783.99M | $12.64B |
Sector | Consumer Cyclical | Health |
52-Week High | $14.60 | $38.70 |
52-Week Low | $4.45 | $28.73 |
Enterprise Value | $731.09M | $15.41B |
Dividend Yield | — | 2.57% |
Trailing returns across standard periods
Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace, which connects sellers with consumers. Its logistics service enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. Jumia generates revenue from Sales of goods, Commissions, Fulfillment, Value-added services, and Marketing & Advertising. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates most of its revenue from the West Africa segment.
Read more on JMIA →Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →